Jonathan C. Javitt - Aug 22, 2023 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Chief Scientist, Director, 10%+ Owner
Signature
/s/ Jonathan C. Javitt
Stock symbol
NRXP
Transactions as of
Aug 22, 2023
Transactions value $
$64,400
Form type
4
Date filed
8/23/2023, 09:24 AM
Previous filing
Feb 14, 2023
Next filing
Aug 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Purchase $64.4K +200K +136.68% $0.32 346K Aug 22, 2023 Direct
holding NRXP Common Stock 12.6M Aug 22, 2023 By the Jonathan Javitt Living Trust F1
holding NRXP Common Stock 1.42M Aug 22, 2023 By the Javitt 2012 Irrevocable Dynasty Trust F2
holding NRXP Common Stock 300K Aug 22, 2023 By the Jonathan Javitt Donor Advised Fund F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by the Jonathan Javitt Living Trust of which the reporting person is the trustee of such trust.
F2 Held by the Javitt 2012 Irrevocable Dynasty Trust of which the reporting person is the grantor of such trust. The reporting person is not a trustee or beneficiary of the Trust, and no beneficiary of the Trust resides in the reporting person's household. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3 Held by the Jonathan Javitt Donor Advised Fund of which the reporting person is the primary advisor of such fund.